Octreotide decreases insulin resistance so that the dosage of insulin used by diabetics can be reduced. Octreotide appears to have no benefits in those with intact insulin reserves (type 2 diabetes). In addition, octreotide has been reported to reduce sulphonylurea-induced hypoglycaemia.
If octreotide is used, anticipate the need to reduce the insulin dosage (studies suggest by up to 50%). Octreotide may affect insulin secretion, and therefore glucose tolerance, and so it would certainly be prudent to monitor the effects of giving octreotide with any of the oral antidiabetics.
© 2006-2022 Last Updated On: 05/19/2022 (0)
Wait 20 seconds...!!!